BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• BioMidwest

  St. Jude Medical’s Riata Leads Recalled Because of the Potential Risk of Serious Injury or Patient Death if the Device Malfunctions

  June 22, 2012

   · 

  1 min read
• MagForce Nanotechnologies Enters into Preclinical Research Agreement to Investigate Nanotherm(R) Therapy in the Gastrointestinal Cancer Field in the USA

  June 22, 2012

   · 

  4 min read
• Drug Development

  Boston Therapeutics, Inc. Completes Enrollment in Phase ll Clinical Trial to Evaluate PAZ320 in Patients With Type 2 Diabetes

  June 22, 2012

   · 

  3 min read
• Drug Development

  Cellceutix Approved by FDA to Proceed With Clinical Trials on Novel Cancer Drug

  June 22, 2012

   · 

  3 min read
• Pharm Country

  Auxilium Pharmaceuticals to Ring The NASDAQ Stock Market Opening Bell

  June 22, 2012

   · 

  1 min read
• Protalix Biotherapeutics, Inc. to Review CHMP Opinion for ELELYSO(TM)

  June 22, 2012

   · 

  1 min read
• BioCapital

  Oxford Finance and Silicon Valley Bank Provide $30 Million Senior Credit Facility to AVANIR Pharmaceuticals

  June 22, 2012

   · 

  3 min read
• Genetown

  Coronado Biosciences Announces the Pricing of Public Offering of Common Stock

  June 22, 2012

   · 

  1 min read
• Drug Development

  Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients

  June 22, 2012

   · 

  1 min read
• Business

  OXiGENE In-Licenses Rights to Promising Program for Neuroendocrine Tumors

  June 22, 2012

   · 

  1 min read